argus

Neuland Laboratories Limited.

NSE: NEULANDLABINE794A0101029,452 Cr

Timeline

Time (IST)TypeMEventSrc
25 Aug, 08:39 pmNeuland Laboratories Limited has informed the Exchange about Credit Ratingnse
25 Aug, 08:39 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
17 Aug, 02:03 pmNeuland Laboratories Ltd - 524558 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
14 Aug, 06:52 pmNeuland Laboratories Limited has informed the Exchange regarding 'Intimation Regarding Completion Of US FDA Inspection'.nse
10 Aug, 06:55 pmTranscript of the Earnings Call conducted on August 5, 2026nse
10 Aug, 06:55 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
05 Aug, 10:21 pmAudio Recording of the Earnings call conducted on August 5, 2026nse
05 Aug, 10:21 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
05 Aug, 04:37 pmDisclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacitynse
05 Aug, 04:30 pmDisclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guaranteense
05 Aug, 04:24 pmNeuland Laboratories Limited has informed the Exchange about Investor Presentationnse
05 Aug, 04:24 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
05 Aug, 04:16 pmNeuland Laboratories Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Press Release on the Financial Results of the Company for the quarter ended June 30, 2026".nse
05 Aug, 04:16 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
05 Aug, 04:08 pmNeuland Laboratories Ltd - 524558 - Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026bse
05 Aug, 04:03 pmNeuland Laboratories Ltd - 524558 - Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026bse
05 Aug, 04:03 pmNeuland Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
31 Jul, 10:11 pmNeuland Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI Listing Regulations'.nse
20 Jul, 06:28 pmNeuland Laboratories Ltd - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026bse
20 Jul, 01:49 pmNeuland Laboratories Ltd - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificatebse
13 Jul, 05:37 pmNeuland Laboratories Limited has informed the Exchange about Credit Ratingnse
13 Jul, 05:37 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
09 Jul, 08:23 pmNeuland Laboratories Limited has informed the Exchange regarding 'Letter to the Shareholders of the Company in relation to the Notice of 42nd Annual General Meeting and the Integrated Annual Report of the Company for FY 2025-26'.nse
09 Jul, 07:40 pmNeuland Laboratories Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26'.nse
09 Jul, 07:32 pmNeuland Laboratories Ltd - 524558 - Reg. 34 (1) Annual Report.bse
05 Jun, 09:58 amIntimation about Schedule of Analyst / Institutional Investor Meeting on June 11, 2026nse
03 Jun, 03:00 pmIntimation about Schedule of Analyst / Institutional Investor Meeting on June 8 & 9, 2026nse
31 May, 07:14 pmIntimation about Schedule of Analyst / Institutional Investor Meeting on June 5, 2026nse
16 May, 04:12 pmTranscript of the Earnings Call conducted on May 12, 2026nse
16 May, 04:12 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
12 May, 07:46 pmNeuland Laboratories Limited has informed the Exchange about Link of Recordingnse
12 May, 07:46 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
12 May, 07:24 pmNeuland Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
12 May, 07:16 pmNeuland Laboratories Limited has informed the Exchange regarding a revised press release dated May 12, 2026, titled "Correction in Press Release Header".nse
12 May, 07:16 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)bse
12 May, 06:02 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Dividend Updatesbse
12 May, 05:58 pmNeuland Laboratories Limited has informed the Exchange regarding 42nd Annual General Meeting Of The Shareholders Of The Company Is Scheduled To Be Held On Tuesday, August 4, 2026'.nse
12 May, 05:50 pmNeuland Laboratories Ltd - 524558 - The Record Date For The Purpose Of Determining The Shareholder Eligible To Receive The Final Dividend For The Financial Year Ended March 31, 2026, Has Been Fixed As July 24, 2026bse
12 May, 05:50 pmNeuland Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 24-Jul-2026.nse
12 May, 05:29 pmDisclosure under Regulation 30 of SEBI Listing Regulationsnse
12 May, 05:25 pmAppointment of Dr. Mauricio Futran (DIN: 11699767), as an Additional Director of the Company, categorized as Non-Executive Non-Independent Directornse
12 May, 05:24 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
12 May, 05:15 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)bse
12 May, 05:14 pmNeuland Laboratories Limited has informed the Exchange regarding a revised press release dated May 12, 2026, titled "Press Release on the Financial Results of the Company for the quarter and year ended March 31, 2026".nse
12 May, 05:08 pmNeuland Laboratories Ltd - 524558 - Corporate Action-Board approves Dividendbse
12 May, 04:47 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
12 May, 04:46 pmNeuland Laboratories Limited has informed the Exchange about Investor Presentationnse
12 May, 04:36 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
12 May, 04:35 pmNeuland Laboratories Limited has informed the Exchange regarding a press release dated May 12, 2026, titled "Press Release on the Financial Results of the Company for the quarter and year ended March 31, 2026".nse
12 May, 04:22 pmAudited Financial Results and recommendation of final dividend for financial year 2025-26nse